AMANDA SWINGLE: Open Payments
NPI 1356066849 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 5 payments from 4 companies in 2025. Trend: 2023 $18 · 2024 $134 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $135 |
| Janssen Pharmaceuticals, Inc | 1 | $95 |
| Novo Nordisk Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
Products named: INGREZZA, INVEGA SUSTENNA, Ozempic, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
